Navigation Links
New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
Date:11/26/2008

scopic Colorectal Procedure simulation received international praise at the September 2008, 11th World Congress of Endoscopic Surgery and the Japanese Society of Endoscopic Surgery (JSES), and at the American College of Surgery (ACS) in San Francisco, CA in October. Professor Watanabe, head of the JSES, said: "It is very exciting to have a way of training how to perform and master this critical procedure. I am sure we will use it to train our surgeons."

Conor P. Delaney, Professor of Surgery, Chief, Division of Colorectal Surgery at Case Western Reserve University, is also excited about the new module. "The laparoscopic colorectal module will transform the way we teach laparoscopic colorectal surgery. I see this as an important part of training, where trainees learn the basic steps on a simple trainer, and then practice their first 20 cases on the Simbionix simulator. That way, by the time they need to perform in a clinical situation, they are already experienced with the procedure."

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. http://www.simbionix.com

    Contact:

    Inbal Mazor
    VP Marketing
    Simbionix
    inbal@simbionix.com
    Tel: +1-216-229-2040


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GeneNews appoints Canadian Colorectal Cancer Advisory Board
2. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
3. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
4. NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER
5. GeneNews launches worlds first blood test for colorectal cancer screening
6. Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
7. Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
8. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
9. Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo
10. Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer
11. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015 AACC welcomed thousands of medical ... Annual Meeting & Clinical Lab Expo in ... meeting showcased revolutionary advancements in clinical testing technology ... providers to diagnose patients quickly and accurately and ... As of Wednesday, July 29, more ...
(Date:7/30/2015)... San Diego , CA (PRWEB) , ... July ... ... Biopharma, announced the successful completion of a field clinical study of its canine ... being developed together with Aratana Therapeutics (Kansas City, KS) and will be marketed ...
(Date:7/30/2015)... HIGHLIGHTS:Q2 2015 Results (all changes are against the ... $697 million compared to $701 million in the second ... changes in foreign currency exchange rates decreased sales by ... By business unit, organic sales growth was 6% in ... , Reported diluted EPS was $0.98 compared to ...
(Date:7/29/2015)... , July 30, 2015 ... la santé, publie ses résultats pour le premier ... commente les résultats. Visionner l,interview ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Au sommaire de ... - Moteurs de croissance - ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... 86 percent and a narrowed net loss for its fiscal ... business, government and education. , ,Revenue for 2005 was $8.3 ... had a $4.2 million net loss, a slight improvement over ... the effect of the firm's growth phase, which also involved ...
... , ,Of the approximately 12,000 people who are diagnosed with ... year, and the rest within 3 years. The only treatments ... the tumor and radiation treatment with the maximum tolerated dose ... of life. Because of this, researchers are racing to find ...
... and angel investors has been "cleaned up" to make ... Act 255 is an incentives package for investors ... apply for tax credits of 25 percent of their ... by the governor on Wednesday, allows groups of investors, ...
Cached Biology Technology:Radiology advance points way to non-invasive brain-cancer treatment 2
(Date:7/30/2015)... VIEW, Calif. , July 30, 2015 /PRNewswire/ ... and services for gene function analysis and biomarker ... Guide RNA (sgRNA) Knockout Library targeting all human ... specifically and permanently "knock out" a gene,s function. ... provides a high throughput screening tool so that ...
(Date:7/23/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software ... ended June 30, 2015.  Revenue for the ... 33% compared to $6.8 million in the same quarter last ... $0.3 million, or $0.01 per diluted share, which compared to ... period a year ago.  Lower revenue and ...
(Date:7/21/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market and ... it has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology ... but also the user using unique personal identifiers ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4
... Laboratory is working closely with Chinese scientists and ... cleaner Beijing and developing sustainable technologies for the ... DOE and China,s Ministry of Science and Technology ... scale deployment of next-generation vehicle technologies. The benefits ...
... One day soon, laboratories may grow synthetically engineered tissues ... a major step forward, Cornell engineers describe in the ... have developed that can nourish growing tissues., The researchers ... mimic a vascular system at the cellular scale and ...
... Capecchi, Ph.D., distinguished professor of human genetics and biology ... Genetics and a Howard Hughes Medical Institute investigator, has ... The announcement was made this morning by the ... The prize recognizes Capecchis pioneering development of knockout mice ...
Cached Biology News:Argonne helps China create cleaner Beijing for 2008 Olympics 2Researchers create system to build transplant tissue 2Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 2Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 3
... uses three Adept CE 4100 high pressure ... rate in one microlitre increaments. The ... provides added flexibility. The WaveQuest ... array detection and provides superior stability . ...
... of samples may be carried out using this ... System control and data processing is provided ... The elegant, powerful and very easy to use ... and 2000., The supplied detector is the ground ...
...
capacity 250 mL...
Biology Products: